Nervonik Secures $13 Million in Series A Funding for Innovative Chronic Pain Solution Nervonik, Inc. has raised $13 million in Series A funding to advance its opioid-free peripheral nerve stimulation therapy, targeting chronic pain relief.

Nervonik Secures $13 Million in Series A Funding for Innovative Chronic Pain Solution #USA #Los_Angeles #Nervonik #Chronic_Pain #PNS_Technology